Directive 1998/79 - In vitro diagnostic medical devices

Please note

This page contains a limited version of this dossier in the EU Monitor.

1.

Current status

This directive was in effect from December  7, 1998 until May 25, 2022 and should have been implemented in national regulation on December  7, 1999 at the latest.

2.

Key information

official title

Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices
 
Legal instrument Directive
Number legal act Directive 1998/79
Original proposal COM(1995)130 EN
CELEX number i 31998L0079

3.

Key dates

Document 27-10-1998
Publication in Official Journal 07-12-1998; Special edition in Romanian: Chapter 13 Volume 025,Special edition in Lithuanian: Chapter 13 Volume 021,Special edition in Slovenian: Chapter 13 Volume 021,Special edition in Maltese: Chapter 13 Volume 021,OJ L 331, 7.12.1998,Special edition in Bulgarian: Chapter 13 Volume 025,Special edition in Hungarian: Chapter 13 Volume 021,Special edition in Latvian: Chapter 13 Volume 021,Special edition in Estonian: Chapter 13 Volume 021,Special edition in Polish: Chapter 13 Volume 021,Special edition in Croatian: Chapter 13 Volume 054,Special edition in Slovak: Chapter 13 Volume 021,Special edition in Czech: Chapter 13 Volume 021
Effect 07-12-1998; Entry into force Date pub. See Art 23
End of validity 25-05-2022
Transposition 07-12-1999; Adoption At the latest See Art 22.1
07-06-2000; Application See Art 22.1

4.

Legislative text

Avis juridique important

|

5.

31998L0079

Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices

Official Journal L 331 , 07/12/1998 P. 0001 - 0037

DIRECTIVE 98/79/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 27 October 1998 on in vitro diagnostic medical devices

THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty establishing the European Community, and in particular Article 100a thereof,

Having regard to the proposal from the Commission (1),

Having regard to the opinion of the Economic and Social Committee (2),

Acting in accordance with the procedure laid down in Article 189b of the Treaty (3),

  • (1) 
    Whereas measures should be adopted for the smooth operation of the internal market; whereas the internal market is an area without internal frontiers in which the free movement of goods, persons, services and capital is ensured;
  • (2) 
    Whereas the content and scope of the laws, regulations and administrative provisions in force in the Member States with regard to the safety, health protection and performance, characteristics and authorisation procedures for in vitro diagnostic medical devices are different; whereas the existence of such disparities creates barriers to trade, and whereas the need to establish harmonised rules has been confirmed by a comparative survey of national legislations carried out on behalf of the Commission;
  • (3) 
    Whereas the harmonisation of national legislation is the only means of removing such barriers to free trade and of preventing new barriers from arising; whereas this objective cannot be achieved in a satisfactory manner by other means by the individual Member States; whereas this Directive lays down only such requirements as are necessary and sufficient to ensure, under the best safety conditions, free movement of the in vitro diagnostic medical devices to which it applies;
  • (4) 
    Whereas the harmonised provisions must be distinguished from measures adopted by the Member States to manage the funding of public health and sickness insurance schemes relating directly or indirectly to such devices; whereas, therefore, the harmonised provisions do not affect the ability of the Member States to implement such measures provided that they comply with Community law;
  • (5) 
    Whereas in vitro diagnostic medical devices should provide patients, users and third parties with a high level of health protection and attain the performance levels originally attributed to them by the manufacturer; whereas, therefore, maintenance or improvement of the level of health protection attained in the Member States is one of the main objectives of this Directive;
  • (6) 
    Whereas, in accordance with the principles set out in the Council resolution of 7 May 1985 on a new approach to technical harmonisation and standards (4), rules regarding the design, manufacture and packaging of relevant products must be confined to the provisions required to meet the essential requirements; whereas, because they are essential, such requirements should replace the corresponding national provisions; whereas the essential requirements, including requirements to minimise and reduce risks, should be applied with discretion, taking into account the technology and practice at the time of design and technical and economic considerations compatible with a high level of protection of health and safety;
  • (7) 
    Whereas the major part of medical devices are covered by Council Directive 90/385/EEC of 20 June 1990 on the approximation of laws relating to active implantable medical devices (5) and Council Directive 93/42/EEC of 14 June 1993 concerning medical devices (6) with the exclusion of in vitro diagnostic medical devices; whereas this Directive seeks to extend the harmonisation to in vitro diagnostic medical devices and whereas, in the...

More

This text has been adopted from EUR-Lex.

 

6.

Sources and disclaimer

For further information you may want to consult the following sources that have been used to compile this dossier:

This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.

 

7.

Full version

This page is also available in a full version containing the summary of legislation, de geconsolideerde versie, the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand and finally the related cases of the European Court of Justice.

The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.

8.

EU Monitor

The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.